Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 20(22): 6538-41, 2010 Nov 15.
Article in English | MEDLINE | ID: mdl-20889341

ABSTRACT

A new class of 2-substituted benzoxazole carboxamides are presented as potent functional 5-HT(3) receptor antagonists. The chemical series possesses nanomolar in vitro activity against human 5-HT(3)A receptors. A chemistry optimization program was conducted and identified 2-aminobenzoxazoles as orally active 5-HT(3) receptor antagonists with good metabolic stability. These novel analogues possess drug-like characteristics and have potential utility for the treatment of diseases attributable to improper 5-HT(3) receptor function, especially diarrhea predominant irritable bowel syndrome (IBS-D).


Subject(s)
Benzoxazoles/chemistry , Benzoxazoles/pharmacology , Drug Discovery , Receptors, Serotonin, 5-HT3/drug effects , Serotonin Antagonists/chemistry , Serotonin Antagonists/pharmacology
2.
J Biomol Screen ; 13(6): 468-75, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18566479

ABSTRACT

Endothelial lipase (EL) is a 482-amino-acid protein from the triglyceride lipase gene family that uses a Ser-His-Asp triad for catalysis. Its expression in endothelial cells and preference for phospholipids rather than triglycerides are unique. Animal models in which it is overexpressed or knocked out indicate EL levels are inversely correlated with high-density lipoprotein cholesterol (HDL-C). HDL-C is commonly referred to as the good form of cholesterol because it is involved in the reverse cholesterol transport pathway, in which excess cholesterol is effluxed from peripheral tissues for excretion or reabsorption. Thus, EL inhibition in humans is expected to lead to increases in HDL levels and possibly a decrease in cardiovascular disease. To discover inhibitors of EL, a coupled assay for EL has been developed, using its native substrate, HDL. Hydrolysis of HDL by EL yields free fatty acids, which are coupled through acyl-CoA synthetase, acyl-CoA oxidase, and horseradish peroxidase to produce the fluorescent species resorufin. This assay was developed into a 5-microL, 1536-well assay format, and a high-throughput screen was executed against the GSK collection. In addition to describing the screening results, novel post-HTS mechanism-of-action studies were developed for EL and applied to 1 of the screening hits as an example.


Subject(s)
Lipase/metabolism , Lipoproteins, HDL/metabolism , Acyl-CoA Oxidase/metabolism , Adenosine Triphosphate/metabolism , Animals , Biological Assay , CHO Cells , Coenzyme A Ligases/metabolism , Cricetinae , Cricetulus , Fatty Acids, Nonesterified/metabolism , Horseradish Peroxidase/metabolism , Humans , Hydrolysis , Kinetics , Lipase/chemistry , Lipase/genetics , Lipase/isolation & purification , Models, Biological , Oxazines/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...